title: Classification of a large anticancer data set by adaptive fuzzy partition.
abstract: An Adaptive Fuzzy Partition (AFP) algorithm, derived from Fuzzy Logic concepts, was used to classify an anticancer data set, including about 1300 compounds subdivided into eight mechanisms of action. AFP classification builds relationships between molecular descriptors and bio-activities by dynamically dividing the descriptor hyperspace into a set of fuzzy subspaces. These subspaces are described by simple linguistic rules, from which scores ranging between 0 and 1 can be derived. The latter values define, for each compound, the degrees of membership of the different mechanisms analyzed. A particular attention was devoted to develop structure-activity relations that have a real utility. Then, well-defined and widely accepted protocols were used to validate the models by defining their robustness and prediction ability. More particularly, after selecting the most relevant descriptors with help of a genetic algorithm, a training set of 640 compounds was isolated by a rational procedure based on Self-Organizing Maps. The related AFP model was then validated with help of a validation set and, above all, of cross-validation and Y-randomization procedures. Good validation scores of about 80% were obtained, underlining the robustness of the model. Moreover, the prediction ability was evaluated with 374 test compounds that had not been used to establish the model and 77% of them were predicted correctly.
authors.affiliation: BioChemics Consulting, 16 rue Leonard de Vinci, F-45074 Orleans Cedex 2, France.
authors.forename: Nadège
authors.initials: N
authors.lastname: Piclin
authors.forename: Marco
authors.initials: M
authors.lastname: Pintore
authors.forename: Christophe
authors.initials: C
authors.lastname: Wechman
authors.forename: Jacques R
authors.initials: JR
authors.lastname: Chrétien
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000145:classification*; D003628:Database Management Systems; D017143:Fuzzy Logic; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents
references.citation: Science. 1992 Oct 16;258(5081):447-51
references.pmid: 1411538
references.citation: J Natl Cancer Inst. 1994 Dec 21;86(24):1853-9
references.pmid: 7990160
references.citation: Science. 1997 Jan 17;275(5298):343-9
references.pmid: 8994024
references.citation: Nat Med. 1995 Jan;1(1):27-31
references.pmid: 7584949
references.citation: Eur J Med Chem. 2001 Apr;36(4):349-59
references.pmid: 11461760
references.citation: J Med Chem. 2001 Sep 27;44(20):3254-63
references.pmid: 11563924
references.citation: J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):228-36
references.pmid: 12546557
references.citation: Environ Toxicol Chem. 2003 May;22(5):983-91
references.pmid: 12729207
references.citation: Eur J Med Chem. 2003 Apr;38(4):427-31
references.pmid: 12750031
references.citation: J Mol Graph Model. 2002 Jan;20(4):269-76
references.pmid: 11858635
references.citation: J Chem Inf Comput Sci. 2002 Mar-Apr;42(2):393-404
references.pmid: 11911709
references.citation: Stat Med. 1994 Mar 15-Apr 15;13(5-7):719-30
references.pmid: 8023045
references.citation: J Natl Cancer Inst. 1989 Jul 19;81(14):1088-92
references.pmid: 2738938
references.citation: J Chem Inf Comput Sci. 2000 Mar-Apr;40(2):367-79
references.pmid: 10761142
references.citation: Mol Pharmacol. 1998 Feb;53(2):241-51
references.pmid: 9463482